Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Interim Statements of Operations and Comprehensive Loss

v3.20.2
Condensed Consolidated Interim Statements of Operations and Comprehensive Loss - USD ($)
3 Months Ended
Jun. 30, 2020
Jun. 30, 2019
Condensed Consolidated Interim Statements of Operations and Comprehensive Loss    
Sales $ 257,908 $ 790,379
Cost of Sales 62,555 336,085
Gross Margin 195,353 454,294
Operating expenses    
Sales and marketing 223,185 583,732
Research and development 353,263 816,523
General and administrative 1,128,510 841,693
Share-based compensation expense (Notes 11) 407,315 287,757
Amortization (Note 4) 23,504 69,314
Depreciation (Note 7) 18,112 23,970
Total operating expenses 2,153,889 2,622,989
Other (income) expenses    
Other expense 74,975 14,296
Other income (37,612) 0
Foreign exchange 11,177 (62,347)
Total other income (expenses) 48,540 (48,051)
Net loss and comprehensive loss for the period $ (2,007,076) $ (2,120,644)
Loss per share - basic and diluted $ (0.39) $ (0.55)
Weighted average number of shares outstanding - basic and diluted 5,126,834 3,858,637